The aims of the study reported herein were to explore the relationship between aspart pharmacokinetics and clinical/demographic factors for subjects with type 1 diabetes undergoing continuous subcutaneous insulin infusion (CSII) during pregnancy and to assess reproducibility within and between subjects. Here, INS is linked to type 1 diabetes mellitus.